Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$56.16

-0.09 (-0.16%)

As of May 8, 9:31 PM ET ·

Financial Highlights (FY 2026)

Revenue

48.34B

Net Income

7.08B

Gross Margin

72.6%

Profit Margin

14.6%

Rev Growth

+1.5%

D/E Ratio

2.44

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	72.6%	72.6%	59.2%	59.2%
Operating Margin	21.5%	19.3%	22.1%	21.3%
Profit Margin	14.6%	13.9%	20.8%	23.5%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	48.34B	47.65B	47.91B	45.13B
Gross Profit	35.11B	34.61B	28.35B	26.71B
Operating Income	10.39B	9.22B	10.61B	9.60B
Net Income	7.08B	6.28B	9.95B	10.61B
Gross Margin	72.6%	72.6%	59.2%	59.2%
Operating Margin	21.5%	19.3%	22.1%	21.3%
Profit Margin	14.6%	13.9%	20.8%	23.5%
Rev Growth	+1.5%	+1.5%	+15.6%	-1.5%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	42.60B	42.60B	44.69B	49.22B
Total Equity	17.44B	17.44B	47.12B	45.92B
D/E Ratio	2.44	2.44	0.95	1.07

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	13.71B	12.84B	15.42B	13.24B
Free Cash Flow	—	—	6.08B	6.45B